<?xml version="1.0" encoding="UTF-8"?>
<p>Up to the 12 March 2020, 396 high-quality genomes of SARS-CoV-2 have been released, displaying in total 301 unique nonsynonymous substitutions that is, mutations associated with amino acid replacements (
 <xref ref-type="fig" rid="veaa034-F1">Fig. 1</xref>). These data have provided useful epidemiological insights into the history of the pandemic, for example, demonstrating multiple introductions into different geographical areas (
 <xref rid="veaa034-B4" ref-type="bibr">Deng et al. 2020</xref>; 
 <xref rid="veaa034-B9" ref-type="bibr">Gudbjartsson et al. 2020</xref>). Using these genomes, the timing of the last common ancestor of the outbreak is estimated to be around late November 2019 (
 <xref rid="veaa034-B16" ref-type="bibr">Rambaut 2020</xref>), with an exponential growth of infections since that date. Estimates of the virus’ evolutionary rate are centred around 8 × 10
 <sup>−4</sup> substitutions per site per year (
 <xref rid="veaa034-B16" ref-type="bibr">Rambaut 2020</xref>; 
 <xref rid="veaa034-B20" ref-type="bibr">Su et al. 2020</xref>), which is broadly in line with those estimated from SARS-CoV-1 and Middle East respiratory syndrome (MERS; 
 <xref rid="veaa034-B1485983" ref-type="bibr">Zhao et al. 2004</xref>; 
 <xref rid="veaa034-B2241566" ref-type="bibr">Dudas et al., 2018</xref>), and about a third of that estimated for influenza B (
 <xref rid="veaa034-B27" ref-type="bibr">Virk et al. 2020</xref>). 
</p>
